Objective determination of capillary refill time by OLED-on-CMOS technology: a prospective observational proof of principle clinically study

In hospitals and clinics around the world, doctors and nurses rely on a simple, ancient trick to check if blood is flowing properly through a patient's tiny vessels. They press a finger against the skin until the area turns pale, then let go and watch how quickly the color returns. This moment, known as capillary refill time, acts as a quick window into the body's microcirculation—the network of microscopic blood vessels that deliver oxygen to every cell. If the color returns slowly, it can signal that the body is struggling to deliver oxygen, a warning sign of shock or infection. Yet, despite its importance, this test has a fundamental flaw: it depends entirely on the human eye and the human stopwatch. The pressure applied by the examiner's finger can vary, the lighting in the room can change, and the timing of the return of color is a matter of personal judgment. These small inconsistencies mean that two different doctors might get different results for the same patient, making it hard to rely on the test for precise medical decisions.

To solve this problem, a team of researchers in Dresden, Germany, set out to build a machine that could perform this test with perfect consistency. They developed a small, handheld device that combines a special type of screen with a sensitive sensor, allowing it to act as both the light source and the eye that watches the skin. The researchers tested this new tool on twenty patients from the general wards at a university hospital, pressing the device against the center of each person's chest. The goal was to see if the machine could measure the time it takes for blood to refill the skin as accurately as a human doctor, but without the guesswork. The results showed that the device worked well, recording times that were very close to the standard human method, but with a level of precision that a person simply cannot achieve.

The device itself is a marvel of modern engineering, built on a technology called OLED-on-CMOS. In plain terms, this means the researchers created a tiny screen that can also act as a camera. When the device is pressed against the skin, the screen lights up with white light, illuminating the area just like a flashlight. At the same time, the same surface detects the light bouncing back from the skin. This allows the machine to see exactly how pale the skin becomes and how quickly the pink color returns, all while ignoring the changing light of the hospital room. A built-in sensor also measures how hard the device is being pressed, ensuring that the pressure is strong enough to blanch the skin but not so strong that it causes harm. The machine waits for a steady, specific amount of pressure, holds it for five seconds, and then automatically starts its internal clock the moment the pressure is released. It stops the clock the instant the skin color returns to normal, recording the exact time down to the fraction of a second.

In the study, the researchers compared the readings from this new digital device against the traditional method, where a doctor presses their own finger against the patient's chest and times the return of color with a stopwatch. They performed these tests on twenty patients, all of whom were classified as ASA I, indicating they were in good physical health with no relevant medical history. The results were remarkably consistent. The doctors using the standard method found that the average time for the skin to return to color was 1.5 seconds. The digital device, performing the same task on the same people, recorded an average time of 1.2 seconds. In thirteen of the twenty patients, the machine measured a slightly faster refill time than the human doctor did. The researchers believe this small difference likely happened because the machine started its timer the instant the pressure was lifted, whereas a human doctor has to physically move their finger away before they can start counting, adding a tiny, invisible delay to their measurement.

Crucially, the study confirmed that the device is safe and does not alter the patient's condition. The researchers monitored the patients' heart rates, blood pressure, and body temperature before and after the tests, and none of these vital signs changed. The device did not cause any skin irritation or redness, proving that the brief contact and the pressure applied were gentle enough for repeated use. The study also highlighted how the machine removes the variables that plague the human method. While the lighting in the room shifted slightly during the human measurements, the device provided its own constant, unchanging light. The pressure applied by the machine was strictly controlled, whereas a human finger might press harder or softer depending on fatigue or habit. By standardizing these factors, the device offers a way to get a true, objective reading of how well the microcirculation is working.

The researchers acknowledge that this was a first step, a proof of concept designed to show that the technology works in a real-world setting. The device is currently connected to a laptop via a cable, which limits how freely it can be moved around a patient's room, and the team notes that further work is needed to see how it performs on different skin types or at different locations on the body. However, the core finding is clear: it is possible to turn a subjective, human-dependent test into an objective, machine-readable measurement. This new approach suggests a future where monitoring the body's smallest blood vessels is as reliable as checking a heartbeat, providing doctors with a clearer, more consistent picture of a patient's health without the uncertainty of human error.